Inhibikase Therapeutics Cash Flow Statement (2020-2025) | IKT

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
-2.64M-2.64M-4.47M-5.04M-4.64M-4.64M-4.49M-4.33M-4.71M-6.20M-4.77M-4.40M-4.78M-5.05M-5.83M-12.93M-14.60M-10.83M-12.77M-13.78M
Depreciation and Depletion (Quarter)
0.00M0.01M0.01M0.16M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.02M
Share-based Compensation (Quarter)
0.59M0.32M0.35M0.27M0.12M0.13M0.10M0.10M0.12M0.12M0.13M0.12M0.05M0.03M0.15M7.91M2.04M4.21M4.53M4.53M
Gains from Investment Securities (Quarter)
0.24M0.07M0.18M0.03M0.07M0.08M0.05M0.09M0.09M0.80M0.02M0.19M0.31M17.22M21.33M25.76M27.23M
Non-cash Items (Quarter)
3.38M0.30M0.65M7.96M
Cash from Operations (Quarter)
-3.93M-4.25M-2.02M-4.10M-3.93M-4.36M-5.50M-3.56M-5.97M-4.57M-4.11M-3.44M-3.87M-5.05M-4.88M-5.35M-4.10M-5.57M-10.59M-7.52M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.00M0.01M0.01M0.16M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.02M
Change in Working Capital
Change in Receivables (Quarter)
0.33M0.25M-0.37M-0.11M-0.06M-0.04M0.01M0.14M0.02M0.02M-0.08M
Change in Account Payables (Quarter)
-1.01M0.17M-0.33M0.54M-0.28M0.05M-0.08M0.37M-0.19M-0.20M-0.02M-0.09M0.48M0.40M0.45M-1.06M0.68M0.91M-1.98M0.54M
Change in Accured Expenses (Quarter)
-0.01M0.25M1.03M0.81M0.86M0.03M-1.34M0.13M-0.84M0.27M0.03M0.40M0.25M-0.47M0.13M0.52M0.83M-0.58M0.72M0.42M
Other Working Capital Changes (Quarter)
-1.07M-1.11M-0.14M0.02M-0.02M0.01M0.76M-0.38M-0.30M-0.03M0.03M0.03M-0.06M0.21M-0.22M0.07M0.05M
Investing Activities
Capital Expenditures (Quarter)
0.20M0.01M
Cash from Investing Activities (Quarter)
-0.04M-20.93M4.96M-5.84M2.55M17.06M-2.12M-3.31M2.54M2.53M-38.76M21.05M9.84M-28.75M-0.10M
Financing Activities
Other financing activities (Quarter)
-0.03M
Cash from Financing Activities (Quarter)
-0.41M41.47M0.03M-0.20M8.58M-0.04M70.00-0.14M0.37M3.24M0.18M99.68M0.03M-0.13M108.57M
Additional items
Change in Cash (Quarter)
-4.34M37.23M-1.99M-4.10M-4.14M-4.40M-26.43M1.41M-3.23M-2.05M12.96M-5.70M-6.81M0.73M-2.17M55.58M16.95M4.30M-39.47M100.95M
Free Cash Flow (Quarter)
-3.93M-4.25M-2.02M-4.10M-3.93M-4.36M-5.70M-3.56M-5.97M-4.57M-4.11M-3.44M-3.87M-5.05M-4.88M-5.35M-4.12M-5.57M-10.59M-7.52M
Net Cash Flow (Quarter)
-4.34M37.23M-1.99M-4.10M-4.14M-4.40M-26.43M1.41M-3.23M-2.05M12.96M-5.70M-6.81M0.73M-2.17M55.58M16.95M4.30M-39.47M100.95M